Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase

Biological Chemistry

Volumn 380, Issue 9, 1999, Pages 1103-1108

  Kolkenbrock, Hansjörg ^a   Essers, Lutz ^b   Ulbrich, Norbert ^a   Will, Horst ^b  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^b InViTek GmbH   (Germany)

Author keywords

Inhibition; MT4 MMP

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGEN TYPE 5; DECORIN; ENZYME PRECURSOR; FIBRONECTIN; GELATIN; LAMININ; MATRIX METALLOPROTEINASE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVATION; ESCHERICHIA COLI; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; CATALYTIC DOMAIN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; PROTEASE INHIBITORS; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SUBSTRATE SPECIFICITY;

ESCHERICHIA COLI;

EID: 0032864044     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.137     Document Type: Article

References (34)

1. Bakowski, B., and Tschesche, H. (1992). Migration of polymorphonuclear leukocytes through human amnion membrane - a scanning electron microscopic study. Biol. Chem. Hoppe-Seyler 373, 529-546.
2. Crawford, H., and Matrisian, L. (1995). Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 14, 234-245.
3. Declaux, D., Delacourt, C., d'Ortho, M., Boyer, V., Lafuma, C., and Harf, A. (1996). Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am. J. Respir. Cell. Mol. Biol. 14, 288-295.
4. Fassina, G., Paglialunga, G., Fontanini, G., Cosimi, A., Perrotta, A., Aluigi, M., Ardizzoni, A., and Albini, A. (1996). Expression of mRNA for gelatinase A and TIMP-2 in cell cultures and tissue samples derived from breast and lung carcinomas. Int. J. Oncol. 8, 253-261.
5. Gilles, C., Polette, M., Seiki, M., Birembaut, P., and Thompson, E. (1997). Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab. Invest. 76, 651-660.
6. Goldberg, G., Marmer, B., Grant, J., Eisen, A., Wilhelm, S., and He, C. (1989). Human 72 K type IV collagenase forms a complex with a tissue inhibitor of metalloproteinase designed TIMP-2. Proc. Natl. Acad. Sci. USA 86, 8207-8211.
7. Goldberg, G., Strongin, A., Collier, I., Genrich, L., and Marmer, B. (1992). Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization complex formation with interstitial collagenase and activation of the proenzme with stromelysin. J. Biol. Chem. 267, 4583-4591.
8. Green, N., and Work, E. (1953). Pancreatic trypsin inhibitor. 2. reaction with trypsin. Biochem. J. 54, 347-352.
9. Knight, C., Willenbrock, F., and Murphy, G. (1992). A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 296, 263-266.
10. Kolkenbrock, H., Orgel, D., Hecker-Kia, A., Noack, W., and Ulbrich, N. (1991). The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor. Eur. J. Biochem. 198, 775-781.
11. Kolkenbrock, H., Orgel, D., Hecker-Kia, A., Zimmermann, J., and Ulbrich, N. (1995). Generation and activity of the ternary gelatinase B/TIMP-1/LMW-stromelysin-1 complex. Biol. Chem. Hoppe-Seyler 376, 495-500.
12. Kolkenbrock, H., Hecker-Kia, A., Orgel, D., Ulbrich, N., and Will, H. (1997). Activation of progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase. Biol. Chem. 378, 71-76.
13. Lichte, A., Kolkenbrock, H., and Tschesche, H. (1996). The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2. FEBS-Lett. 397, 277-282.
14. Lottenberg, R., Christensen, U., Jackson, C., and Coleman, P. (1981). Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. Methods Enzymol. 80, 341-361.
15. Masui, Y., Takemoto, T., Sakakibara, S., and Hori, H. (1977). Synthetic substrates for vertebrate collagenase. Biochem. Med. 17, 215-221.
16. Matsumoto, S., Katoh, M., Saito, S., Watanabe, T., and Masuho, Y. (1997). Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA. Biochim. Biophys. Acta 1354, 159-170.
17. 1-antitrypsin by human neutrophil collagenase. In: Matrix Metalloproteinases and Inhibitors, H. Birkedal-Hansen, Z. Werb, H. Welgus and H. van Wart, eds., (Stuttgart, Jena, New York: Gustav Fischer Verlag), pp. 78-79.
18. Murphy, G., Allan, J., Willenbrock, F., Cockett, M., O'Connel, J., and Docherty, A. (1992). The role of the C-terminal domain in collagenase and stromelysin specificity. J. Biol. Chem. 267, 9612-9618.
19. Nagase, A., Fields, C., and Fields, G. (1994). Design and characterization of a fluorogenic substrate selectively hydrolysed by stromelysin-1 (matrix metalloproteinase 3). J. Biol. Chem. 269, 20952-20957.
20. Pei, D., and Weiss, S. (1996). Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271, 9135-9140.
21. Puente, X., Pendás, A., Llano, E., Valesco, G.,and López-Otin, C. (1996). Molecular cloning of a noval membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res. 56, 944-946.
22. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. (1994). A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 61-65.
23. Shofuda, K., Yasumutsu, H., Nishihashi, A., Miki, K., and Miyazaki, K. (1997). Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MTS-MMPs with and without transmembrane domain. J. Biol. Chem. 272, 9749-9754.
24. Stetler-Stevenson, W.G. (1995). Progelatinase A activation during tumor cell invasion. Invasion Metastasis 14, 259-268.
25. Takino, T., Sato, H., Shinagawa, A., and Seiki, M. (1995). Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J. Biol. Chem. 270, 23013-23020.
26. Visscher, D., Hoyhtya, M., Ottosen, S., Liang, C., Sarcar, F., Crissman, J., and Fridman, R. (1994). Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int. J. Cancer 58, 1-6.
27. Watanabe, H., Nakanishi, I., Yamashita, K., Hayakawa, T., and Okada, Y. (1993). Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J. Cell. Sci. 104, 991-999.
28. Wenzel, H.R., Engelbrecht, S., Reich, H., Mondry, W., and Tschesche, H. (1980). Synthesis and analytical use of 3-carboxypropionyl-alanyl-alanyl-valine-4-nitroanilide, a specific substrate for human leukocyte elastase. Hoppe-Seyler's Z. Physiol. Chem. 361, 1413-1416.
29. Wilhelm, S., Collier, I., Marmer, B., Eisen, A., Grant, J., and Goldberg, G. (1989). SV 40 - transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264, 17213-17221.
30. Will, H., and Hinzmann, B. (1995). cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem. 231, 602-608.
31. Will, H., Atkinson, S., Butler, G., Smith, B., and Murphy, G. (1996). The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. J. Biol. Chem. 271, 17119-17123.
32. Willenbrock, F., Crabbe, T., Slocombe, P., Sutton, C., Docherty, A., Cockett, M., O'Shea, M., Brocklehurst, K., Philips, I., and Murphy, G. (1993). The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions. A kinetic analysis of the inhibition of gelatinase A. Biochemistry 32, 4330-4337.
33. Yasumitsu, H., Miyazaki, K., Umenishi, F., Koshikawa, N., and Umeda, M. (1992). Comparison of extracellular matrix-degrading activities between 64-kDa and 90-kDa gelatinases purified in inhibitor-free forms from human schwannoma cells. J. Biochem. (Tokyo) 111, 74-80.
34. Yoshida, N., Everitt, M.T., Neurath, H., Woodbury, R.G., and Powers, J.C. (1980). Substrate specificity of two chymotrypsin-like proteases from rat mast cells. Studies with peptide 4-nitroanilides and comparison with cathepsin G. Biochemistry 19, 5799-5804.